Preclinical study showed PDIA1 and PDIA5 protect cells from oxidative stress, maintain mitochondrial function, and are involved in androgen receptor regulation.
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...
Minoxidil, the active medical ingredient in products like Rogaine, is a well-known treatment for hair loss, but has poor ...
An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, ...
Leishmaniasis belongs to the class of neglected tropical diseases (NTDs) that particularly affect people in the poorest ...
STOCKHOLM, SE / ACCESS Newswire / October 14, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the ...
Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
Phytochelatin synthases (PCSs) produce phytochelatins—tiny, cysteine-rich peptides that bind and neutralize toxic metal ions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results